Medifast (MED) Stock Price

Medifast Inc is primarily active in the nutrition and weight management industry.

Medifast Inc faces competition from various companies operating in the health and wellness industry. Some of the main competitors of Medifast Inc include Weight Watchers International Inc, Nutrisystem Inc, Herbalife Nutrition Ltd, and WW International Inc. These companies offer similar products and services aimed at promoting healthy living, weight management, and overall wellbeing. Medifast Inc strives to differentiate itself from its competitors through innovative products, personalized customer support, and a strong focus on scientific research and development. Through continuous efforts, Medifast Inc aims to maintain its position and popularity among consumers in the competitive market.

Medifast Inc, a leading provider of health and wellness products, has a rich history and background. Established in 1980, Medifast has been dedicated to helping people achieve their weight loss and healthy lifestyle goals. With over four decades of experience, the company has developed science-based programs that combine proper nutrition, support, and education to deliver effective and sustainable results. Medifast's commitment to innovation and quality has earned them a strong reputation in the industry. By offering a wide range of nutritional products and personalized support, Medifast continues to empower individuals on their journey towards better health and wellbeing.

Medifast Inc has achieved several significant milestones throughout its history. Some notable achievements include expanding their product lineup to offer a wide range of weight management and nutrition products. The company has also witnessed rapid growth and increased market presence, becoming a leading provider of healthy living products and programs. Medifast Inc has received numerous industry accolades and recognition for their innovative approach to healthy living, including being named as one of Forbes' "100 Most Trustworthy Companies" and earning the Good Housekeeping Seal of Approval. Additionally, Medifast Inc has successfully established a strong network of independent OPTAVIA coaches, empowering individuals to achieve optimal health and financial well-being.

Medifast Inc is primarily present in the United States, Canada, and certain selected international markets.

Medifast Inc represents a strong commitment to health and wellness through its values and corporate philosophy. With a focus on scientific research and evidence-based nutrition, the company offers effective weight loss and management solutions. Medifast prioritizes customer satisfaction, transparency, and integrity, making it a trusted name in the industry. By providing personalized support and a comprehensive approach to well-being, Medifast empowers individuals to achieve their health goals. With its dedication to high-quality products and services, Medifast Inc continues to lead the way in transformative wellness solutions.

9 analysts currently rate the Medifast stock: 0 recommend buying, 4 holding and 5 selling. For 2026, analysts expect Medifast to generate revenue of 287.70 M USD and earnings per share of -1.15 USD.

Medifast Analyst Price Targets 2026

Converted at the current exchange rate, the Medifast share trades at 10.29 EUR (11.53 USD).

The Medifast share (MED) is listed on 7 stock exchanges, including: NYSE (MED), London (0K05.L), SIX (Zürich) (MDF.SW), Frankfurt (MDF.F), München (MDF.MU), Düsseldorf (MDF.DU).

Medifast Inc is a leading American company in the health and nutrition industry. The company's business model is based on the production and sale of dietary supplements, meal replacement shakes, snacks, and other products for weight loss and healthy nutrition. Medifast Inc also offers training programs and support for people who want to control their weight and implement a healthy diet. An important part of Medifast Inc's business model is the OPTAVIA® brand. OPTAVIA® is an innovative concept that provides comprehensive support for nutrition and weight loss. The program includes personalized nutritional counseling, access to online tools and resources, and support from a coach. The OPTAVIA® brand is one of Medifast Inc's main sources of revenue and has contributed to the company's growth and expansion. Medifast Inc also offers other brands such as Medifast®, Thrive by Medifast™, and Jason Pharmaceuticals™. Medifast® offers meal replacement shakes, bars, and soups that are intended to promote effective weight loss. Thrive by Medifast™ is a brand based on the principle that a healthy diet is the best foundation for optimal physical and mental health. Jason Pharmaceuticals™ is a brand specializing in the development and marketing of products that support women in various stages of their lives (such as pregnancy, menopause, etc.). Medifast Inc distributes its products and services through various channels such as direct sales, online orders, and distribution partners. The company has an extensive network of over 30,000 independent distribution partners who serve as OPTAVIA® coaches. These coaches are trained nutrition experts who provide their clients with personalized nutrition plans and support in achieving their weight loss goals. Medifast Inc's business model is based on a holistic approach to healthy eating and weight loss. The company is committed to offering high-quality products based on scientific knowledge and providing its customers with comprehensive support in implementing a healthy lifestyle. Medifast Inc has built a strong market position through its commitment to quality and customer satisfaction and is a leading provider of dietary supplements and meal replacement products in the US and the world. Overall, Medifast Inc's business model is focused on high-quality products, personalized support, and a wide range of offerings for customers. Medifast Inc has become an important company in the health and nutrition industry and is dedicated to providing its customers with high-quality and comprehensive support in implementing a healthy lifestyle.

The expected revenue of Medifast is 287.70 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Medifast is -12.61 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medifast is currently -10.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medifast stock.

The price-to-sales ratio (P/S) of Medifast is currently 0.44. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medifast stock.

The Eulerpool Quality Score for Medifast is 0/10.

The ISIN of Medifast is US58470H1014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medifast is 889384. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medifast is MED. The ticker symbol is used to trade Medifast shares on the stock exchange.